Abstract
C20H30CdN4O4P2S4, triclinic, P1̄ (no. 2), a = 9.0764(3) Å, b = 9.3969(3) Å, c = 9.6964(3) Å, α = 86.516(3)°, β = 63.362(3)°, γ = 75.250(3)°, V = 713.50(4) Å3, Z = 1, Rgt(F) = 0.0166, wRref(F2) = 0.0462, T = 100(2) K.

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
| Crystal: | Yellow prism |
| Size: | 0.22 × 0.14 × 0.11 mm |
| Wavelength: | Cu Kα radiation (1.54184 Å) |
| μ: | 10.21 mm−1 |
| Diffractometer, scan mode: | XtaLAB Synergy, ω-scans |
| θmax, completeness: | 67.1°, >99% |
| N(hkl)measured, N(hkl)unique, Rint: | 15508, 2560, 0.021 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2560 |
| N(param)refined: | 162 |
| Programs: | CrysAlisPRO [1], SHELX [2], [3], WinGX and ORTEP [4] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| Cd | 0.500000 | 0.500000 | 1.000000 | 0.01167(6) |
| S1 | 0.62710(5) | 0.21727(4) | 0.89421(5) | 0.01518(9) |
| S2 | 0.82782(5) | 0.48870(4) | 0.80199(5) | 0.01587(9) |
| P1 | 0.84648(5) | 0.27358(4) | 0.78453(5) | 0.01265(10) |
| O1 | 0.98987(15) | 0.17908(13) | 0.82879(14) | 0.0187(2) |
| O2 | 0.92541(14) | 0.21281(13) | 0.61007(13) | 0.0154(2) |
| N1 | 0.41685(17) | 0.56317(15) | 0.79881(15) | 0.0140(3) |
| N2 | 0.49294(19) | 0.93956(16) | 0.54745(17) | 0.0203(3) |
| C1 | 1.0169(2) | 0.2188(2) | 0.9563(2) | 0.0202(4) |
| H1A | 0.927426 | 0.198654 | 1.055805 | 0.024* |
| H1B | 1.012810 | 0.324990 | 0.957880 | 0.024* |
| C2 | 1.1894(2) | 0.1272(2) | 0.9325(2) | 0.0236(4) |
| H2A | 1.216210 | 0.157193 | 1.011919 | 0.035* |
| H2B | 1.275656 | 0.141812 | 0.830011 | 0.035* |
| H2C | 1.188779 | 0.022857 | 0.940202 | 0.035* |
| C3 | 1.0940(2) | 0.2290(2) | 0.4983(2) | 0.0199(4) |
| H3A | 1.179689 | 0.184106 | 0.535561 | 0.024* |
| H3B | 1.091571 | 0.334694 | 0.484423 | 0.024* |
| C4 | 1.1388(2) | 0.1523(2) | 0.3478(2) | 0.0220(4) |
| H4A | 1.255519 | 0.152879 | 0.273481 | 0.033* |
| H4B | 1.059711 | 0.203682 | 0.306990 | 0.033* |
| H4C | 1.130265 | 0.050186 | 0.365003 | 0.033* |
| C5 | 0.4415(2) | 0.68340(18) | 0.72021(19) | 0.0151(3) |
| H5 | 0.500008 | 0.743068 | 0.741411 | 0.018* |
| C6 | 0.3846(2) | 0.72530(19) | 0.60771(19) | 0.0174(3) |
| C7 | 0.2985(2) | 0.6367(2) | 0.5781(2) | 0.0206(4) |
| H7 | 0.258755 | 0.661239 | 0.502101 | 0.025* |
| C8 | 0.2717(2) | 0.5126(2) | 0.6608(2) | 0.0209(4) |
| H8 | 0.212395 | 0.451349 | 0.643116 | 0.025* |
| C9 | 0.3327(2) | 0.47946(19) | 0.76937(19) | 0.0170(3) |
| H9 | 0.314491 | 0.394049 | 0.825640 | 0.020* |
| C10 | 0.4139(2) | 0.8573(2) | 0.5218(2) | 0.0203(4) |
| H10A | 0.373770 | 0.882130 | 0.446030 | 0.024* |
Source of material
The Cd[S2P(OEt)2]2 precursor was prepared in high yield from the in situ reaction of Cd(NO3)2 ⋅ 4H2O (Acros Organic; 15.42 g, 0.05 mol), EtOH (Merck; 12.25 mL, 0.21 mol), P2S5 (Sigma-Aldrich; 11.11 g, 0.05 mol) and 50% w/w NaOH solution (Merck; 8.80 mL, 0.11 mol). The 1,2-bis(3-pyridylmethylene)hydrazine ligand was prepared in high yield from the 2:1 reaction (reflux) of 3-picolylamine (Aldrich; 2.03 mL, 0.02 mol) and hydrazinium hydroxide (Merck; 0.49 mL, 0.01 mol) in ethanol solution (Merck; 5 mL). The title compound was obtained by mixing a suspension of Cd[S2P(OEt)2]2 (0.50 g, 1.04 mmol) and 1,2-bis(3-pyridylmethylene)hydrazine (0.22 g, 1.05 mmol) in dimethylformamide (Merck; 5 mL), followed by stirring for 30 min. at 373 K. The solution was filtered and the filtrate collected in a sample vial containing acetonitrile (Merck; 1 mL). Yellow block crystals formed after one day. Yield: 0.39 g, (54.1%, based on Cd[S2P(OEt)2]2). M. pt (MelTemp Melting Point Apparatus): 426–428 K. Elem. Anal. (Leco TruSpec Micro CHN Elemental Analyser): Calc. for C20H30CdN4O4P2S4: C, 34.66; H, 4.36; N, 8.09%. Found: C, 34.51; H, 4.08; N, 8.31%. IR (Bruker Vertex 70 V equipped with Platinum ATR from 400 to 80 cm−1): 1192(w) ν(C—O); 1012(s) ν(P—O); 661(s) ν(P—S); 379(w) ν(Cd—N); 287(m) ν(Zn—S).
Experimental details
H atoms were geometrically placed (C—H = 0.95–0.99 Å) and refined as riding with Uiso(H) = 1.2–1.5Ueq(C).
Discussion
The potentially bidentate, bridging ligands, n-pyridylaldazines (n-PyAld), i.e. n-NC5H4C(H)=N—N=C(H)C5H4N-n, for n = 3 and 4, form one-dimensional coordination polymers in their 1:1 adducts with zinc(II) and cadmium(II) dithiophosphates [−S2P(OR)2] [5]. However, very different coordination geometries and topologies of the chains are found in these structures. Thus, for {Zn[S2P(OR)2](n-PyAld)}2, a distorted tetrahedral N2S2 coordination geometry and a twisted chain is found when n = 3 and R = Et [6]. By contrast, when n = 3 and R = isopropyl (iPr), a linear chain with a step-ladder topology and an octahedral trans-N2S4 donor set is found [7]. In the case when n = 4, and R = Et [8] and cyclohexyl (Cy) [9], zigzag coordination polymers are found but with tetrahedral N2S2 and octahedral cis-N2S4 donor sets, respectively. A greater homogeneity in the coordination polymers formed by cadmium(II) is noted in that trans-N2S4 donor sets are found. Thus, for {Cd[S2P(OR)2](n-PyAld)}2, when n = 3 and R = Me [10], iPr [11], [12] and Cy [13], linear coordination polymers, with a step-ladder topology, are found. When n = 4, and R = Et [14] and iPr [11], linear coordination polymers are found. However, it should be noted that zero-dimensional species are sometimes isolated when polymeric species might otherwise be anticipated. An example is seen in the structure of binuclear {Zn[S2P(O-iPr)2]2}2(4-PyAld) [15]. More intriguing are monodentate (terminal) modes of coordination of the 4-PyAld ligand have been noted in some dithiocarbamate (−S2CNR2) derivatives, namely Zn[S2CN(Me)CH2CH2OH]2(4-PyAld), with a square-pyramidal geometry based on a NS4 donor set [16] and Cd[S2CN(nPr)CH2CH2OH]2(4-PyAld)2 [n-propyl = nPr], with a trans-N2S4 donor set [17]. In continuation of systematic studies in this area, herein, the crystal and molecular structures of {Cd[S2P(OEt)2]2(3-PyAld)}n, (I), are described.
The cadmium(II) atom in (I) lies on a centre of inversion (the symmetry related dithiophosphate ligand is generated by the symmetry operation (i) 1 − x, 1 − y, 2 − z) and the 3-PyAld molecule is disposed about a centre of inversion (the other half of the 3-PyAld ligand is related by (ii) 1 − x, 2 − y, 1 − z). A view of the coordination geometry is shown in the figure (70% probability displacement ellipsoids) which highlights the trans-N2S4 donor set. While to a first approximation, the dithiophosphate ligands are symmetrically chelating to define a plane defined by four S atoms, there is a disparity of 0.026 Å in the Cd—S1 [2.6741(4) Å] and Cd—S2 [2.7003(4) Å] bond lengths. Nevertheless, the P1—S1, S2 [1.9862(6) and 1.9963(6) Å] differ by only 0.01 Å. Significantly, more symmetric coordination modes are noted in the R = Me [10] and iPr [12] analogues but, the situation in (I) matches that seen in the R = Cy structure [13] where the difference in the Cd—S bond lengths amounts to 0.021 Å. The Cd—N bond length is 2.3830(13) Å. The lack of systematic trends in the Zn, Cd—S, N bond lengths is well-known for these systems, even if control of polymer formation and topology was achieved [18], [19], [20]. The coordination geometry in (I) is defined by the trans-N2S4 donor set and is based on an octahedron with the maximum deviation from the ideal cis angle manifested in the acute S1—Cd—S2 chelate angle of 77.236(12)°.
The linear chain in (I), with a step-ladder topology, is parallel to [0 1 −1]. Chains are connected into a two-dimensional array by π⋯π stacking between pyridyl rings [inter-centroid separation for Cg(N1,C5–C9)⋯Cg(N1,C5–C9)iii = 3.6794(10) Å for (iii) 1 − x, 1 − y, 1 − z] and pyridyl-C—H⋯O(alkoxy) [C7—H7⋯O2iii: H7⋯O2iii = 2.42 Å, C7⋯O2iii = 3.318(2) Å with angle at H7 = 158°] interactions. Layers stack along [−2 2 1] and inter-digitate with sucessive layers but there are no directional interactions between them.
Acknowledgements
Sunway University Sdn Bhd is thanked for financial support of this work through Grant no. STR-RCTR-RCCM-001-2019.
References
1. Rigaku Oxford Diffraction: CrysAlis PRO. Rigaku Corporation, Oxford, UK (2018).Search in Google Scholar
2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed
3. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central
4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J. Appl. Cryst. 45 (2012) 849–854.10.1107/S0021889812029111Search in Google Scholar
5. Tiekink, E. R. T.: Perplexing coordination behaviour of potentially bridging bipyridyl-type ligands in the coordination chemistry of zinc and cadmium 1,1-dithiolate compounds. Crystals 8 (2018) article no. 18 (29 pages).10.3390/cryst8010018Search in Google Scholar
6. Tan, Y. S.; Tiekink, E. R. T.: Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)zinc(II)], {C20H30N4O4P2S4Zn}n. Z. Kristallogr. NCS 235 (2020) 297–299.10.1515/ncrs-2019-0621Search in Google Scholar
7. Avila, V.; Tiekink, E. R. T.: catena-Poly[[bis(O,O′-diisopropyl dithiophosphato-κ2S,S′)zinc(II)]-μ-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′]. Acta Crystallogr. E62 (2006) m3530–m3531.10.1107/S160053680605001XSearch in Google Scholar
8. Tan, Y. S.; Tiekink, E. R. T.: Crystal structure of catena-{poly[bis(O,O′-diethyldithiophosphato-S)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)-zinc(II)] di-acetonitrile solvate}, {C20H30N4O4P2S4Zn.2C2H3N}n. Z. Kristallogr. NCS 234 (2019) 895–897.10.1515/ncrs-2019-0116Search in Google Scholar
9. Chen, D.; Lai, C. S.; Tiekink, E. R. T.: catena-Poly[[bis(O,O′-dicyclohexyldithiophosphato-κ2,S,S′)zinc(II)]-μ-1,2-bis(4-pyridylmethylene)hydrazine-κN:N′]. Acta Crystallogr. E61 (2005) m2052–m2054.10.1107/S1600536805029466Search in Google Scholar
10. Tan, Y. S.; Tiekink, E. R. T.: Crystal structure of catena-[(bis(O,O′-dimethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n. Z. Kristallogr. NCS 235 (2020) 339–341.10.1515/ncrs-2019-0654Search in Google Scholar
11. Lai, C. S.; Tiekink, E. R. T.: Polymeric topologies in cadmium(II) dithiophosphate adducts of the isomeric n-pyridinealdazines, n = 2, 3 and 4. Z. Kristallogr. C. M. 221 (2006) 288–293.10.1524/zkri.2006.221.4.288Search in Google Scholar
12. Tan, Y. S.; Tiekink, E. R. T.: A redetermination of the crystal structure of catena-[(bis(O,O′-isopropyl dithiophosphato-S,S′)-(μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C24H38CdN4O4P2S4}n. Z. Kristallogr. NCS 235 (2020) 253–255.10.1515/ncrs-2019-0641Search in Google Scholar
13. Lai, C. S.; Tiekink, E. R. T.: Delineating the principles controlling polymer formation and topology in zinc(II)- and cadmium(II)-dithiophosphate adducts of diimine-type ligands. J. Molec. Struct. 796 (2006) 114–118.10.1016/j.molstruc.2006.03.036Search in Google Scholar
14. Tan, Y. S.; Tiekink, E. R. T.: Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n. Z. Kristallogr. NCS 235 (2020) 335–337.10.1515/ncrs-2019-0653Search in Google Scholar
15. Tan, Y. S.; Tiekink, E. R. T.: Crystal structure of tetrakis(O,O′-diisopropyldithiophosphato-κ2S,S′)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-κ2N:N′)zinc(II), C36H66N4O8P4S8Zn2. Z. Kristallogr. NCS 234 (2019) 827–829.10.1515/ncrs-2019-0133Search in Google Scholar
16. Broker, G. A.; Jotani, M. M.; Tiekink, E. R. T.: Bis[N-2-hydroxyethyl, N-methyldithiocarbamato-κ2S,S)′-4-{[(pyridin-4-ylmethylidene)hydrazinylidene}methyl]pyridine-κN1) zinc(II): crystal structure and Hirshfeld surface analysis. Acta Crystallogr. E73 (2017) 1458–1464.10.1107/S2056989017012725Search in Google Scholar PubMed PubMed Central
17. Broker, G. A.; Tiekink, E. R. T.: Bis[N-(2-hydroxyethyl)-N-propyldithiocarbamato-κ2S,S′]bis-(4-{[(pyridin-4-ylmethylidene)hydrazinylidene]methyl}pyridine-κN1)cadmium. Acta Crystallogr. E67 (2011) m320–m321.10.1107/S1600536811004508Search in Google Scholar PubMed PubMed Central
18. Lai, C. S.; Liu, S.; Tiekink, E. R. T.: Steric control over polymer formation and topology in adducts of zinc dithiophosphates formed with bridging bipyridine ligands. CrystEngComm 6 (2004) 221–226.10.1039/b407335eSearch in Google Scholar
19. Lai, C. S.; Tiekink, E. R. T.: Engineering polymers with variable topology – bipyridine adducts of cadmium dithiophosphates. CrystEngComm 6 (2004) 593–605.10.1039/b414847aSearch in Google Scholar
20. Chen, D.; Lai, C. S.; Tiekink, E. R. T.: Supramolecular aggregation in diimine adducts of zinc(II) dithiophosphates: controlling the formation of monomeric, dimeric, polymeric (zig-zag and helical), and 2-D motifs. CrystEngComm 8 (2006) 51–58.10.1039/B513393ASearch in Google Scholar
©2019 Yee Seng Tan et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 Public License.
Articles in the same Issue
- Frontmatter
- Synthesis and crystal structure of bis{5-fluorine-2-(((4-(1-(methoxy-imino)ethyl)phenyl) imino)methyl)phenolato-κ2N,O}copper(II), C32H28CuF2N4O4
- Redetermination of the crystal structure of N′-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazide monohydrate, C16H17FN2O4
- The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2
- Crystal structure of (E)-N-[4-(1H)-imidazolyl phenyl]-(2-methylphenyl)methanimine, C17H15N3
- The crystal structure of 1-benzyl-4-(2-(phenylethynyl)phenyl)-1H-1,2,3-triazole, C23H17N3
- Crystal structure of catena-poly[{μ2-1,5-bis(diphenylphosphanyl)pentane-κ2P:P′}dichloridocadmium(II)], C29H30CdCl2P2
- Crystal structure of methyl (E)-N2-((3-methylquinolin-8-yl)sulfonyl)-Nω′-nitro-L-argininate - ethanol (1/1), C19H28N6O7S
- The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh
- Crystal structure of N-(amino(pyrazin-2-yl)methylene)-6-methylpyridin-1-ium-3-carbohydrazonate-κ3O,N,N′)-(dinitrato-κ1O)zinc(II), C12H12N8O7Zn
- The crystal structure of dichlorido-(tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′)chromium(III) chloride — methanol (1/3), CrC27H33Cl3N7O3
- Crystal structure of catena-poly[aqua(μ4-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ8O,O′:O′,N:N′,O′′:O′′,O′′′))silver(I)], C10H24Ag2N2O10S2
- Crystal structure of bis(μ3-oxido)-bis(μ2–2,3,4,5-tetrafluorobenzoato-κ2O:O′)-bis(2,3,4,5-tetrafluorobenzoato-κO)-oktakis(3-chlorobenzyl-κC)tetratin(IV), C84H52Cl8F16O10Sn4
- Crystal structure of (E)-1-{4-[(4-fluoro-2-hydroxybenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15FN2O2
- Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)zinc(II)], {C20H30N4O4P2S4Zn}n
- Crystal structure of methyl 2-(4-(3-iodopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C15H12IN3O2
- Crystal structure of hexacarbonyl-(μ2-methanoato-k2O:O′)-(μ2–bis(di-p-tolylphosphino)cyclohexylamine-κ2P:P′)dirhenium(I), C42H45NO8P2Re2
- The cocrystal structure of 1′-hydroxy-1H,1′H-[5,5′-bitetrazol]-1-olate and 1,10-phenanthrolin-1-ium, C14H10N10O2
- The crystal structure of 1-benzyl-2-((4-(tert-butyl)phenyl)ethynyl)pyridin-1-ium bromide,C24H24BrN
- Crystal structure of (5,5′-bitetrazole-1,1′-diolate)-bis(1,10-phenanthroline)-copper(II), C26H16CuN12O2
- Crystal structure of bis(ammonium) diaqua-tetrakis(4-hydroxybenzoato)-manganese(II) tetrahydrate, [NH4]2[C28H24MnO14] ⋅ 4(H2O)
- The crystal structure of 3-chloro-1-hydrazino-2,4,6-trinitrobenzene, C6H4ClN5O6
- Crystal structure of catena-[(μ2-pyrazine-κ2N:N′)-bis(O,O′-di-ethyldithiophosphato-κ2S,S′)cadmium(II)], {C12H24CdN2O4P2S4}n
- Crystal structure of catena-poly[(μ2-pyrazine-N,N′)-bis(O,O′-di-isopropyldithiophosphato-S,S′)cadmium(II) acetonitrile di-solvate], [C16H32CdN2O4P2S4⋅2(C2H3N)]n
- Crystal structure of catena-poly{(μ2-N1,N2-bis[(pyridin-4-yl)methyl]ethanediamide-κ2N:N′)-bis(O,O′-di-isopropyldithiophosphato-κ1S)zinc(II)} — acetonitrile (1/1), C26H42N4O6P2S4Zn⋅C2H3N
- Crystal structure of tetraqua-bis(4-(hydroxymethyl)benzoato-κO)cobalt(II), C16H22O10Co
- Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n
- Crystal structure of catena-poly[(μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)-bis(O,O′-dimethyl dithiophosphato-κ2-S,S′)cadmium(II)], {C16H22CdN4O4P2S4}n
- Crystal structure of catena-poly[(bis(O,O′-diethyl dithiophosphato-κ2S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)cadmium(II)], {C20H30CdN4O4P2S4}n
- The crystal structure of catena-poly[(E)-2-(((5-((trimethylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol], C12H15N3OS2Sn
- Crystal structure of dichlorido(N-o-tolyl-1,1-di-p-tolylphosphanamine–κ1P)-(methoxydi-p-tolylphosphane-κ1P)palladium(II), C36H39Cl2NOP2Pd
- The crystal structure of the triclinic polymorph of hexameric (trimethylsilyl)methyllithium, C24H66Li6Si6
- Crystal structure of bis(hydroxydi(pyridin-2-yl)methanolato-κ3N,N′O)cobalt(III) 7,7,8,8-tetracyanoquinodimethane, C34H22CoN8O4
- Synthesis and crystal structure of benzyl 5-oxo-5-phenyl-2-(quinolin-2-yl)pentanoate, C27H23NO3
- Crystal structure of 5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-(2,2-dichloroacetyl)-3,4-dihydro-2 H-benzo[b][1,4]oxazine-7-carboxylate, C19H19Cl2NO5
- Crystal structure of dipentyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C18H28O6
- The crystal structure of catena-poly[diaqua-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)dicadmium(II)], C30H18Cd2N2O10S2
- Crystal structure of 2,7-diiodo-1,3,6,8-tetramethyl-bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine, C14H14B2F4I2N4
- A dinuclear Eu(III) complex in the crystal structure of dodecaaqua-bis(μ2-4-(1H-tetrazol-5-yl)benzoato-κ2O:O′) bis(5-(4-carboxylatophenyl)tetrazol-1-ide) tetrahydrate, C32H50Eu2N16O24
- Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S
- Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
- Crystal structure of 4-dimethylamino-pyridin-1-ium uracil-1-acetate, C13H16N4O4
- Crystal structure of dimethylammonium 5-fluorouracil-1-acetate, C8H12N3O4F
- Crystal structure of bis(N′-((5-(ethoxycarbonyl)-1H-pyrrol-2-yl)methylene)-N-ethylcarbamohydrazonothioato-κ2N,O)nickel(II), C22H30N8O4S2Ni
- Crystal structure of chlorido-(η5-pentamethylcyclopentadienyl)-((bis-pyrazol-1-yl)methane-κ2N,N′) rhodium(III) hexafluorophosphate. (C17H23ClN4RhF6P)
- The crystal structure of 5-(benzofuran-2-carbonyl)-N-cyclohexyl-5,6-dihydrophenanthridine-6-carboxamide, C29H26N2O3
- The crystal structure of 2-oxo-2H-chromen-4-yl acetate, C11H8O4
- The crystal structure of 2-nitroisophthalic acid, C8H5NO6
- Crystal structure of 3-fluoro-9-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino [2′,1′:1,6]pyrazino[2,3-b]quinoxaline, C19H17FN4O
- Crystal structure of (4-fluorobenzyl-κC)(bis(2-hydroxyethyl) carbamodithioato-κ2S,S′)(2,2′-imino-diethanolato-κ3N,O,O′)tin(IV), C16H25FN2O4S2Sn
- Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18BrF3N2O3S
- Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S
- The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridomanganate(II), C10H16Cl4MnN2
- The crystal structure of 3-carboxy-5-methylpyridin-1-ium-2-carboxylate, C8H7NO4
- Crystal structure of bis(3-methoxy-N-(1-(pyridin-2-yl)ethylidene)benzohydrazonato κ3O,N,N′)zinc(II), C30H28N6O4Zn
- Crystal structure of dichlorido-(4,4′-dichloro-2,2′-bipyridine-κ2N,N′)platinum(II) — acetone (1/1), C13H12Cl4N2PtO
- Crystal structure of diethyl 6,12-bis(4-fluorophenyl)-2,10-dimethoxy-3,9-diphenyl-3,9-diazatetracyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C42H42F2N2O6
- Synthesis and crystal structure of (1E,3E)-2-hydroxy-5-methylisophthalaldehyde O,O-di(2-((((E)-(2-hydroxynaphthalen-1-yl)methylene)amino)oxy)ethyl) dioxime, C35H32N4O7
- The crystal structure of 2-phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2
- Crystal structure of 7-(2-{4-[(4-bromophenyl)methyl]piperazin-1-yl}ethoxy)-2H-chromen-2-one, C22H23BrN2O3
- Crystal structure of bis-[N-(3-ethyl-1-pyrazin-2-yl-ethylidene)-3-bromo-benzoic acid-hydrazonato-κ3O,N,N′)]-cadmium(II), C30H28N8O2Br2Cd
- Crystal structure of 6-(4-fluorophenyl)-4-methoxy-2H-pyran-2-one, C12H9FO3
- Crystal structure of 3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid, C14H18O4
- The crystal structure of 3-bromo-6-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, C13H19BBrNO3
- The crystal structure of 6-methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate–2,4-dihydroxybenzoic acid (1/1), C30H36O8
- The crystal structure of (5-chloro-2-hydroxy-N-(4-methoxy-2-oxidobenzylidene)benzohydrazonato-κ3N,O,O′)-(pyridine-κ1N)copper(II), C20H16ClCuN3O4
- Crystal structure of (E)-2-cyano-N′-(1-(3-ethylpyrazin-2-yl)ethylidene)acetohydrazide, C11H3N5O
- Crystal structure of (2,7-dihexyl-9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), C51H56OP2
- Crystal structure of 5-((bis(pyridin-2-ylmethyl)amino)methyl)quinolin-8-ol, C22H20N4O
- Crystal structure of 3-(2-(5-(4-fluorophenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4-yl)-2H-chromen-2-one, C28H20FN3O2S
- The crystal structure of [(tetra-μ2-2,6-difluorobenzoato-κ2O:O′)-bis-(2,6-difluorobenzoato-κ2O:O′)-bis-(1,10-phenanthroline-κ2N:N′)]dierbium(III) C66H34N4O12F12Er2
- Crystal structure of bis(3-chloro-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-k3N,N′,O)nickel(II), C26H20N8O2Cl2Ni
- Crystal structure of (E)-3-(3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one, C27H21N5O
- Crystal structure of (E)-N′-((4-aminophenyl)sulfonyl)-N,N-dimethylformimidamide, C9H13N3O2S
- Crystal structure of η6-p-cymene-iodido-(N-isopropyl-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C19H26IN2F6Ru
- Crystal structure of 6-iodo-3-phenyl-2-propylquinazolin-4(3H)-one, C17H15IN2O
- Low temperature redetermination of the crystal structure of catena-poly[[tri-4-fluorobenzyltin(IV)]μ2-pyridine-4-carboxylato-κ2N:O], {C27H22F3NO2Sn}n
- Crystal structure of bis(2-propyl-1H-benzo[d]imidazol-3-ium) tetrachloridozincate(II), C10H13Cl4N2Zn
- The crystal structure of (Z)-3-hydrazono-5-nitroindolin-2-one – dimethyl sulfoxide (1/1), C8H6N4O3
- Crystal structure of bis-[N-(1-pyrazin-2-yl-ethylidene)-cyanoacetic acid-hydrazonato-κ3O,N,N′)]-zinc(II), C18H16N10O2Zn
- Crystal structure and photochromism of 1-(2,5-dimethyl-3-thienyl)-2-[2-methyl-5-(benzaldoxime)-3-thienyl] perfluorocyclopentene, C23H17F6NOS2
Articles in the same Issue
- Frontmatter
- Synthesis and crystal structure of bis{5-fluorine-2-(((4-(1-(methoxy-imino)ethyl)phenyl) imino)methyl)phenolato-κ2N,O}copper(II), C32H28CuF2N4O4
- Redetermination of the crystal structure of N′-(3-ethoxy-2-hydroxybenzylidene)-4-fluorobenzohydrazide monohydrate, C16H17FN2O4
- The crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl) ethylidene)-2-hydroxybenzohydrazide, C15H12ClFN2O2
- Crystal structure of (E)-N-[4-(1H)-imidazolyl phenyl]-(2-methylphenyl)methanimine, C17H15N3
- The crystal structure of 1-benzyl-4-(2-(phenylethynyl)phenyl)-1H-1,2,3-triazole, C23H17N3
- Crystal structure of catena-poly[{μ2-1,5-bis(diphenylphosphanyl)pentane-κ2P:P′}dichloridocadmium(II)], C29H30CdCl2P2
- Crystal structure of methyl (E)-N2-((3-methylquinolin-8-yl)sulfonyl)-Nω′-nitro-L-argininate - ethanol (1/1), C19H28N6O7S
- The crystal structure of trans-carbonyl-(diphenylcyclohexyl-phosphine-κP)iodidomethyl-(2-oxopyridin-1(2H)-olato-κ2O,O′)rhodium(III), C25H28INO3PRh
- Crystal structure of N-(amino(pyrazin-2-yl)methylene)-6-methylpyridin-1-ium-3-carbohydrazonate-κ3O,N,N′)-(dinitrato-κ1O)zinc(II), C12H12N8O7Zn
- The crystal structure of dichlorido-(tris(2-benzimidazolylmethyl)amine-κ4N,N′,N′′,N′′′)chromium(III) chloride — methanol (1/3), CrC27H33Cl3N7O3
- Crystal structure of catena-poly[aqua(μ4-piperazine-1,4-bis(2-hydroxypropanesulfonato-κ8O,O′:O′,N:N′,O′′:O′′,O′′′))silver(I)], C10H24Ag2N2O10S2
- Crystal structure of bis(μ3-oxido)-bis(μ2–2,3,4,5-tetrafluorobenzoato-κ2O:O′)-bis(2,3,4,5-tetrafluorobenzoato-κO)-oktakis(3-chlorobenzyl-κC)tetratin(IV), C84H52Cl8F16O10Sn4
- Crystal structure of (E)-1-{4-[(4-fluoro-2-hydroxybenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15FN2O2
- Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-N,N′)zinc(II)], {C20H30N4O4P2S4Zn}n
- Crystal structure of methyl 2-(4-(3-iodopyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C15H12IN3O2
- Crystal structure of hexacarbonyl-(μ2-methanoato-k2O:O′)-(μ2–bis(di-p-tolylphosphino)cyclohexylamine-κ2P:P′)dirhenium(I), C42H45NO8P2Re2
- The cocrystal structure of 1′-hydroxy-1H,1′H-[5,5′-bitetrazol]-1-olate and 1,10-phenanthrolin-1-ium, C14H10N10O2
- The crystal structure of 1-benzyl-2-((4-(tert-butyl)phenyl)ethynyl)pyridin-1-ium bromide,C24H24BrN
- Crystal structure of (5,5′-bitetrazole-1,1′-diolate)-bis(1,10-phenanthroline)-copper(II), C26H16CuN12O2
- Crystal structure of bis(ammonium) diaqua-tetrakis(4-hydroxybenzoato)-manganese(II) tetrahydrate, [NH4]2[C28H24MnO14] ⋅ 4(H2O)
- The crystal structure of 3-chloro-1-hydrazino-2,4,6-trinitrobenzene, C6H4ClN5O6
- Crystal structure of catena-[(μ2-pyrazine-κ2N:N′)-bis(O,O′-di-ethyldithiophosphato-κ2S,S′)cadmium(II)], {C12H24CdN2O4P2S4}n
- Crystal structure of catena-poly[(μ2-pyrazine-N,N′)-bis(O,O′-di-isopropyldithiophosphato-S,S′)cadmium(II) acetonitrile di-solvate], [C16H32CdN2O4P2S4⋅2(C2H3N)]n
- Crystal structure of catena-poly{(μ2-N1,N2-bis[(pyridin-4-yl)methyl]ethanediamide-κ2N:N′)-bis(O,O′-di-isopropyldithiophosphato-κ1S)zinc(II)} — acetonitrile (1/1), C26H42N4O6P2S4Zn⋅C2H3N
- Crystal structure of tetraqua-bis(4-(hydroxymethyl)benzoato-κO)cobalt(II), C16H22O10Co
- Crystal structure of catena-[(bis(O,O′-diethyl dithiophosphato-S,S′)-μ2-1,2-bis(4-pyridylmethylene)hydrazine-N,N′)cadmium(II)], {C20H30CdN4O4P2S4}n
- Crystal structure of catena-poly[(μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)-bis(O,O′-dimethyl dithiophosphato-κ2-S,S′)cadmium(II)], {C16H22CdN4O4P2S4}n
- Crystal structure of catena-poly[(bis(O,O′-diethyl dithiophosphato-κ2S,S′)-μ2-1,2-bis(3-pyridylmethylene)hydrazine-κ2N:N′)cadmium(II)], {C20H30CdN4O4P2S4}n
- The crystal structure of catena-poly[(E)-2-(((5-((trimethylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol], C12H15N3OS2Sn
- Crystal structure of dichlorido(N-o-tolyl-1,1-di-p-tolylphosphanamine–κ1P)-(methoxydi-p-tolylphosphane-κ1P)palladium(II), C36H39Cl2NOP2Pd
- The crystal structure of the triclinic polymorph of hexameric (trimethylsilyl)methyllithium, C24H66Li6Si6
- Crystal structure of bis(hydroxydi(pyridin-2-yl)methanolato-κ3N,N′O)cobalt(III) 7,7,8,8-tetracyanoquinodimethane, C34H22CoN8O4
- Synthesis and crystal structure of benzyl 5-oxo-5-phenyl-2-(quinolin-2-yl)pentanoate, C27H23NO3
- Crystal structure of 5,5-dimethyl-3-oxocyclohex-1-en-1-yl 4-(2,2-dichloroacetyl)-3,4-dihydro-2 H-benzo[b][1,4]oxazine-7-carboxylate, C19H19Cl2NO5
- Crystal structure of dipentyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C18H28O6
- The crystal structure of catena-poly[diaqua-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)-(μ4-5-(benzo[d]thiazol-2-yl)benzene-1,3-dicarboxylate-κ4O,O′:O′′,O′′′)dicadmium(II)], C30H18Cd2N2O10S2
- Crystal structure of 2,7-diiodo-1,3,6,8-tetramethyl-bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine, C14H14B2F4I2N4
- A dinuclear Eu(III) complex in the crystal structure of dodecaaqua-bis(μ2-4-(1H-tetrazol-5-yl)benzoato-κ2O:O′) bis(5-(4-carboxylatophenyl)tetrazol-1-ide) tetrahydrate, C32H50Eu2N16O24
- Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S
- Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2
- Crystal structure of 4-dimethylamino-pyridin-1-ium uracil-1-acetate, C13H16N4O4
- Crystal structure of dimethylammonium 5-fluorouracil-1-acetate, C8H12N3O4F
- Crystal structure of bis(N′-((5-(ethoxycarbonyl)-1H-pyrrol-2-yl)methylene)-N-ethylcarbamohydrazonothioato-κ2N,O)nickel(II), C22H30N8O4S2Ni
- Crystal structure of chlorido-(η5-pentamethylcyclopentadienyl)-((bis-pyrazol-1-yl)methane-κ2N,N′) rhodium(III) hexafluorophosphate. (C17H23ClN4RhF6P)
- The crystal structure of 5-(benzofuran-2-carbonyl)-N-cyclohexyl-5,6-dihydrophenanthridine-6-carboxamide, C29H26N2O3
- The crystal structure of 2-oxo-2H-chromen-4-yl acetate, C11H8O4
- The crystal structure of 2-nitroisophthalic acid, C8H5NO6
- Crystal structure of 3-fluoro-9-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino [2′,1′:1,6]pyrazino[2,3-b]quinoxaline, C19H17FN4O
- Crystal structure of (4-fluorobenzyl-κC)(bis(2-hydroxyethyl) carbamodithioato-κ2S,S′)(2,2′-imino-diethanolato-κ3N,O,O′)tin(IV), C16H25FN2O4S2Sn
- Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-bromophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18BrF3N2O3S
- Crystal structure and anti-inflammatory activity of (3E,5E)-1-((4-chlorophenyl)sulfonyl)-3-(pyridin-4-ylmethylene)-5-(2-(trifluoromethyl)benzylidene)piperidin-4-one, C25H18ClF3N2O3S
- The crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium tetrachloridomanganate(II), C10H16Cl4MnN2
- The crystal structure of 3-carboxy-5-methylpyridin-1-ium-2-carboxylate, C8H7NO4
- Crystal structure of bis(3-methoxy-N-(1-(pyridin-2-yl)ethylidene)benzohydrazonato κ3O,N,N′)zinc(II), C30H28N6O4Zn
- Crystal structure of dichlorido-(4,4′-dichloro-2,2′-bipyridine-κ2N,N′)platinum(II) — acetone (1/1), C13H12Cl4N2PtO
- Crystal structure of diethyl 6,12-bis(4-fluorophenyl)-2,10-dimethoxy-3,9-diphenyl-3,9-diazatetracyclo[6.4.0.02,7.04,11]dodecane-1,5-dicarboxylate, C42H42F2N2O6
- Synthesis and crystal structure of (1E,3E)-2-hydroxy-5-methylisophthalaldehyde O,O-di(2-((((E)-(2-hydroxynaphthalen-1-yl)methylene)amino)oxy)ethyl) dioxime, C35H32N4O7
- The crystal structure of 2-phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2
- Crystal structure of 7-(2-{4-[(4-bromophenyl)methyl]piperazin-1-yl}ethoxy)-2H-chromen-2-one, C22H23BrN2O3
- Crystal structure of bis-[N-(3-ethyl-1-pyrazin-2-yl-ethylidene)-3-bromo-benzoic acid-hydrazonato-κ3O,N,N′)]-cadmium(II), C30H28N8O2Br2Cd
- Crystal structure of 6-(4-fluorophenyl)-4-methoxy-2H-pyran-2-one, C12H9FO3
- Crystal structure of 3-methyl-3-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)butanoic acid, C14H18O4
- The crystal structure of 3-bromo-6-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, C13H19BBrNO3
- The crystal structure of 6-methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate–2,4-dihydroxybenzoic acid (1/1), C30H36O8
- The crystal structure of (5-chloro-2-hydroxy-N-(4-methoxy-2-oxidobenzylidene)benzohydrazonato-κ3N,O,O′)-(pyridine-κ1N)copper(II), C20H16ClCuN3O4
- Crystal structure of (E)-2-cyano-N′-(1-(3-ethylpyrazin-2-yl)ethylidene)acetohydrazide, C11H3N5O
- Crystal structure of (2,7-dihexyl-9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphane), C51H56OP2
- Crystal structure of 5-((bis(pyridin-2-ylmethyl)amino)methyl)quinolin-8-ol, C22H20N4O
- Crystal structure of 3-(2-(5-(4-fluorophenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4-yl)-2H-chromen-2-one, C28H20FN3O2S
- The crystal structure of [(tetra-μ2-2,6-difluorobenzoato-κ2O:O′)-bis-(2,6-difluorobenzoato-κ2O:O′)-bis-(1,10-phenanthroline-κ2N:N′)]dierbium(III) C66H34N4O12F12Er2
- Crystal structure of bis(3-chloro-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-k3N,N′,O)nickel(II), C26H20N8O2Cl2Ni
- Crystal structure of (E)-3-(3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)-1-phenylprop-2-en-1-one, C27H21N5O
- Crystal structure of (E)-N′-((4-aminophenyl)sulfonyl)-N,N-dimethylformimidamide, C9H13N3O2S
- Crystal structure of η6-p-cymene-iodido-(N-isopropyl-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C19H26IN2F6Ru
- Crystal structure of 6-iodo-3-phenyl-2-propylquinazolin-4(3H)-one, C17H15IN2O
- Low temperature redetermination of the crystal structure of catena-poly[[tri-4-fluorobenzyltin(IV)]μ2-pyridine-4-carboxylato-κ2N:O], {C27H22F3NO2Sn}n
- Crystal structure of bis(2-propyl-1H-benzo[d]imidazol-3-ium) tetrachloridozincate(II), C10H13Cl4N2Zn
- The crystal structure of (Z)-3-hydrazono-5-nitroindolin-2-one – dimethyl sulfoxide (1/1), C8H6N4O3
- Crystal structure of bis-[N-(1-pyrazin-2-yl-ethylidene)-cyanoacetic acid-hydrazonato-κ3O,N,N′)]-zinc(II), C18H16N10O2Zn
- Crystal structure and photochromism of 1-(2,5-dimethyl-3-thienyl)-2-[2-methyl-5-(benzaldoxime)-3-thienyl] perfluorocyclopentene, C23H17F6NOS2